glp-1 euglycemic dka When the Transition Goes Wrong: A Rare Case of Diabetic Ketoalkalosis After Transitioning to Tirzepatide in Insulin-dependent Type 2 Diabetes Frontiers | Severe euglycemic ketoacidosis

Semaglutide, generally, has shown greater efficacy in weight loss compared to Liraglutide in clinical trials

Always consult with a qualified healthcare provider before starting any peptide regimen

Some of the drugs mentioned are investigational and have not been approved by the FDA or other regulatory agencies for the uses discussed.

Progesterone concentrations were measured using a commercial radioimmunoassay kit validated for bovine serum

Newer agents like retatrutide show even greater potential but are not yet commercially available

supplemented with 10% fetal bovine serum (Cultilab), 100 IU/ml of penicillin, and 100 g/ml of streptomycin (Sigma-Aldrich, Saint Louis, MO, USA)